Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.

Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2023), Lancet, 402, 1991 - 2003

Authors' reply to Oke and Welch.

Darby SC. et al, (2023), BMJ, 382

Ki67 and breast cancer mortality in women with invasive breast cancer.

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Taylor C. et al, (2023), BMJ, 381

Risk of breast cancer death after a diagnosis of early invasive breast cancer.

MacKenzie M. et al, (2023), BMJ, 381

Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?

Kirby AM. et al, (2023), BMJ, 381

Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting.

Kirby AM. et al, (2023), Clin Oncol (R Coll Radiol), 35, 347 - 350

Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970-2009.

Duane FK. et al, (2022), Clin Transl Radiat Oncol, 36, 132 - 139

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150

Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophageal doses published 2013–2018

Duane F. et al, (2020), European Journal of Cancer, 138, S83 - S84

Eligibility for Partial Breast Radiotherapy in England.

Taylor CW. et al, (2020), Clin Oncol (R Coll Radiol), 32, 217 - 220

Heart failure after treatment for breast cancer.

Boekel NB. et al, (2020), Eur J Heart Fail, 22, 366 - 374

International Variation in Criteria for Internal Mammary Chain Radiotherapy.

Duane FK. et al, (2019), Clin Oncol (R Coll Radiol), 31, 453 - 461

Cardiac Structure Doses in Women Irradiated for Breast Cancer in the Past and Their Use in Epidemiological Studies.

Duane FK. et al, (2019), Pract Radiat Oncol, 9, 158 - 171

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452

Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors.

Jacobse JN. et al, (2019), Int J Radiat Oncol Biol Phys, 103, 595 - 604

Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.

Taylor C. et al, (2018), J Clin Oncol, 36, 2288 - 2296

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer.

Boekel NB. et al, (2018), Br J Cancer, 119, 408 - 418

Neoadjuvant chemotherapy for early breast cancer - Author's reply.

McGale P. et al, (2018), Lancet Oncol, 19

Load More

Include forthcoming?